HCA Healthcare Inc (NYSE: HCA) on Friday, soared 2.23% from the previous trading day, before settling in for the closing price of $406.48. Within the past 52 weeks, HCA’s price has moved between $215.96 and $416.72.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 6.95%. The company achieved an average annual earnings per share of 18.28%. With a float of $185.65 million, this company’s outstanding shares have now reached $265.54 million.
Considering the fact that the conglomerate employs 310000 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 49.46%, operating margin of 14.93%, and the pretax margin is 12.38%.
HCA Healthcare Inc (HCA) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Care Facilities industry stocks is more important than anything else. The insider ownership of HCA Healthcare Inc is 28.06%, while institutional ownership is 65.28%. The most recent insider transaction that took place on Sep 12 ’24, was worth 3,221,340. In this transaction EVP and Chief Clinical Officer of this company sold 8,358 shares at a rate of $385.42, taking the stock ownership to the 29,678 shares. Before that another transaction happened on Sep 12 ’24, when Company’s Officer proposed sale 8,358 for $385.42, making the entire transaction worth $3,221,340.
HCA Healthcare Inc (HCA) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 18.28% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.00% during the next five years compared to 12.21% growth over the previous five years of trading.
HCA Healthcare Inc (NYSE: HCA) Trading Performance Indicators
HCA Healthcare Inc (HCA) is currently performing well based on its current performance indicators. A quick ratio of 0.94 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.57. Likewise, its price to free cash flow for the trailing twelve months is 21.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 21.31, a number that is poised to hit 4.96 in the next quarter and is forecasted to reach 24.95 in one year’s time.
Technical Analysis of HCA Healthcare Inc (HCA)
Compared to the last year’s volume of 1.14 million, its volume of 1.29 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 86.08%. Additionally, its Average True Range was 9.12.
During the past 100 days, HCA Healthcare Inc’s (HCA) raw stochastic average was set at 98.47%, which indicates a significant increase from 96.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 25.78% in the past 14 days, which was higher than the 22.98% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $391.49, while its 200-day Moving Average is $337.74. Nevertheless, the first resistance level for the watch stands at $420.20 in the near term. At $424.87, the stock is likely to face the second major resistance level. The third major resistance level sits at $432.59. If the price goes on to break the first support level at $407.81, it is likely to go to the next support level at $400.09. Now, if the price goes above the second support level, the third support stands at $395.42.
HCA Healthcare Inc (NYSE: HCA) Key Stats
Market capitalization of the company is 107.24 billion based on 261,914K outstanding shares. Right now, sales total 64,968 M and income totals 5,242 M. The company made 17,492 M in profit during its latest quarter, and 1,461 M in sales during its previous quarter.
